← The Wire
OSTXNYSE
OS Therapies Inc
Pharmaceutical Preparations · DE · CIK 1795091
OS Therapies develops and commercializes treatments for osteosarcoma and other solid tumors
$76M
Market cap
$2.24
Last close
+19.1%
1D
+23.1%
5D
2.0M
Volume
Price · last 39 sessions+34.9%
May 4L $1.66 · H $2.24Jun 29
64
Total filings
May 18, 2026
Last filing
12/31
Fiscal year end
10-QQUARTERLY REPORTMay 18, 20268-KReg FD DisclosureApr 30, 20268-KMaterial Agreement · Company UpdateApr 2, 2026424B5PROSPECTUS SUPPLEMENTApr 2, 20268-KCompany UpdateMar 31, 202610-KANNUAL REPORTMar 31, 20268-KMaterial Agreement · New Debt / ObligationMar 6, 20268-KCompany UpdateFeb 13, 20268-KMaterial Agreement · Equity IssuanceJan 12, 202610-QQUARTERLY REPORTNov 14, 20258-KExecutive Change · Shareholder VoteOct 21, 2025DEFA14ACURRENT REPORTOct 17, 20258-KReg FD Disclosure · Company UpdateOct 17, 20258-KCompany UpdateSep 30, 20258-KMaterial Agreement · Equity IssuanceSep 2, 20258-KAgreement Terminated · Company UpdateAug 26, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSAug 25, 2025DEF 14APROXY STATEMENTAug 25, 2025424B5PROSPECTUS SUPPLEMENTAug 25, 20258-KResults of OperationsAug 19, 202510-QQUARTERLY REPORTAug 18, 20258-KBylaw AmendmentAug 15, 2025S-1REGISTRATION STATEMENTAug 4, 20258-KMaterial Agreement · Equity IssuanceJul 14, 20258-KMaterial Agreement · Equity IssuanceJun 27, 20258-KMaterial Agreement · Equity IssuanceJun 24, 2025S-1REGISTRATION STATEMENTMay 23, 20258-KResults of OperationsMay 16, 202510-QQUARTERLY REPORTMay 15, 20258-KAcquisition / Disposition · Equity IssuanceApr 15, 20258-KShareholder VoteApr 9, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 2, 20258-KCompany UpdateApr 2, 20258-KResults of OperationsMar 31, 202510-KANNUAL REPORTMar 31, 2025DEF 14APROXY STATEMENTFeb 28, 2025S-1REGISTRATION STATEMENTJan 31, 20258-KExecutive Change · Material AgreementJan 29, 20258-KCompany UpdateJan 15, 20258-KMaterial Agreement · Equity IssuanceJan 14, 2025S-1/AREGISTRATION STATEMENTJan 3, 20258-KMaterial Agreement · Equity IssuanceJan 3, 20258-KMaterial Agreement · Equity IssuanceDec 30, 2024S-1/AREGISTRATION STATEMENTNov 27, 20248-KResults of OperationsNov 15, 202410-QQUARTERLY REPORTNov 15, 2024S-1REGISTRATION STATEMENTNov 12, 20248-KMaterial Agreement · Equity IssuanceNov 1, 20248-KExecutive ChangeOct 28, 2024SC 13GSC 13GAug 28, 20248-KCompany UpdateAug 22, 20248-KResults of OperationsAug 15, 202410-QQUARTERLY REPORTAug 14, 2024424B4PROSPECTUSAug 1, 2024S-1/AREGISTRATION STATEMENTJun 13, 2024S-1/AREGISTRATION STATEMENTJun 7, 2024S-1REGISTRATION STATEMENTMay 30, 202410-QQUARTERLY REPORTMay 20, 2024S-1/AREGISTRATION STATEMENTJan 25, 2024S-1/AREGISTRATION STATEMENTDec 22, 2023S-1/AREGISTRATION STATEMENTMay 22, 2023S-1/AREGISTRATION STATEMENTApr 24, 2023S-1/AREGISTRATION STATEMENTApr 13, 2023S-1REGISTRATION STATEMENTMar 31, 2023
Similar companies
Comparable business profile · signals at a glance